Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection

March 12, 2020

Phase I results for rectally administered microbicide gel formulated with IQP-0528

March 12, 2020

Safety and PK data presented for GS-9722

March 12, 2020

In SIV infection, gut integrity is retained, not repaired

March 12, 2020

Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP

March 11, 2020

Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial

March 11, 2020

Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen

March 10, 2020

CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI

March 10, 2020

New phase III trials evaluate switch to doravirine/islatravir in HIV patients on other regimens

March 3, 2020

ViiV Healthcare presents new antivirals for HIV infection

Feb. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...